These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Effects of nonstatin lipid drug therapy on high-density lipoprotein metabolism. Rader DJ Am J Cardiol; 2003 Apr; 91(7A):18E-23E. PubMed ID: 12679199 [TBL] [Abstract][Full Text] [Related]
11. Current understanding of the role of high-density lipoproteins in atherosclerosis and senescence. Nofer JR; Walter M; Assmann G Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1071-86. PubMed ID: 16292998 [TBL] [Abstract][Full Text] [Related]
12. HDL and arteriosclerosis: beyond reverse cholesterol transport. Nofer JR; Kehrel B; Fobker M; Levkau B; Assmann G; von Eckardstein A Atherosclerosis; 2002 Mar; 161(1):1-16. PubMed ID: 11882312 [TBL] [Abstract][Full Text] [Related]
13. Drugs in development: targeting high-density lipoprotein metabolism and reverse cholesterol transport. Duffy D; Rader DJ Curr Opin Cardiol; 2005 Jul; 20(4):301-6. PubMed ID: 15956827 [TBL] [Abstract][Full Text] [Related]
14. Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice. Escola-Gil JC; Calpe-Berdiel L; Palomer X; Ribas V; Ordonez-Llanos J; Blanco-Vaca F Front Biosci; 2006 May; 11():1328-48. PubMed ID: 16368520 [TBL] [Abstract][Full Text] [Related]
15. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Camont L; Chapman MJ; Kontush A Trends Mol Med; 2011 Oct; 17(10):594-603. PubMed ID: 21839683 [TBL] [Abstract][Full Text] [Related]
16. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. von Eckardstein A; Nofer JR; Assmann G Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):13-27. PubMed ID: 11145929 [TBL] [Abstract][Full Text] [Related]
17. The paradox of dysfunctional high-density lipoprotein. Ansell BJ; Fonarow GC; Fogelman AM Curr Opin Lipidol; 2007 Aug; 18(4):427-34. PubMed ID: 17620860 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia. Le Goff W; Guerin M; Chapman MJ Pharmacol Ther; 2004 Jan; 101(1):17-38. PubMed ID: 14729390 [TBL] [Abstract][Full Text] [Related]
20. Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity. Luoma PV Pharmacol Toxicol; 1997 Aug; 81(2):57-64. PubMed ID: 9298501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]